X4 Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.About XFOR
X4 Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. It is focused on mavorixafor which is being marketed in the U.S. under the trade name xolremdi.
XFOR Key Statistics
Stock Snapshot
The current X4 Pharmaceuticals(XFOR) stock price is $3.50, with a market capitalization of 347.51M. The stock trades at a price-to-earnings (P/E) ratio of -3.38.
As of 2026-09-08, X4 Pharmaceuticals(XFOR) stock has fluctuated between $3.19 and $4.15. The current price stands at $3.50, placing the stock +9.7% above today's low and -15.7% off the high.
X4 Pharmaceuticals(XFOR) shares are trading with a volume of 2.32M, against a daily average of 373.9K.
During the past year, X4 Pharmaceuticals(XFOR) stock moved between $2.80 at its lowest and $4.83 at its peak.
During the past year, X4 Pharmaceuticals(XFOR) stock moved between $2.80 at its lowest and $4.83 at its peak.
XFOR News
X4 Pharmaceuticals ( (XFOR) ) has issued an update. X4 Pharmaceuticals, a Boston-based biopharmaceutical company specializing in therapies for rare hematology...
X4 Pharmaceuticals (XFOR) announced the outcome of its Type C Meeting with the FDA related to the global 4WARD Phase 3 clinical trial. The purpose of the meetin...
(RTTNews) - X4 Pharmaceuticals (XFOR) announced positive outcome of Type C Meeting with the FDA related to the global 4WARD Phase 3 clinical trial. The purpose...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.